Jose David Mendoza-Mendoza

Mr. Jose David Mendoza-Mendoza

Instituto de biotecnologia, Universidad Nacional de Colombia, Bogotá, Colombia
orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 July 2025 in RSC Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
DADaniel Alejandro Castellar Almonacid
Daniel Alejandro Castellar Almonacid
ACAndrea Barragán Cárdenas
Andrea Barragán Cárdenas
KRKarla Geraldine Rodríguez-Mejia
Karla Geraldine Rodríguez-Mejia
LMLaura Angélica Maldonado-Sanabria
Laura Angélica Maldonado-Sanabria
NANatalia Ardila-Chantré
Natalia Ardila-Chantré
RFRicardo Fierro-Medina
Ricardo Fierro-Medina
Previous studies show that the palindromic peptide RWQWRWQWR, derived from bovine lactoferricin (LfcinB), exhibits selective in vitro cytotoxicity against cervical, breast, and prostate cancer cells.

6 June 2025 in ACS Omega
Verified
Journal Article
Open access
DPDavid Alexander Parada-Suárez
David Alexander Parada-Suárez
JMJose David Mendoza-Mendoza
Jose David Mendoza-Mendoza
KHKevin Andrey Huertas-Ortiz
Kevin Andrey Huertas-Ortiz
JRJuan Esteban Reyes-Calderón
Juan Esteban Reyes-Calderón
JMJhon Erick Rivera Monroy
Jhon Erick Rivera Monroy
ZMZuly Jenny Rivera Monroy
Zuly Jenny Rivera Monroy
Whey adulteration in milk is a widespread issue that often escapes detection by conventional methods due to its similar composition and minimal impact on milk’s sensory characteristics. This study addresses this challenge by evaluating synthetic peptides derived from caseinomacropeptide (CMP) as potential in-house standards for detecting whey adulteration in milk using LC–MS. Two principal peptides, MAIPPKKNQDKTEIPTINT (CMP-1), derived from pepsin digestion of CMP, and TEIPTINT (CMP-3), obtained through a double digestion with pepsin followed by trypsin, were synthesized, purified, and comprehensively characterized to assess their viability as biomarkers. Isomerism in CMP-1 was initially observed through LC–MS and confirmed as cis–trans proline–proline isomerism by 2D-NMR analyses (TOCSY and ROESY), which complicates its application as a standard. Consequently, CMP-3, an isomerism-free derivative, was synthesized and demonstrated stability in both pepsin and trypsin digestions. The use of three surrogates for quantifying CMP was evaluated: CMP, CMP-1, and CMP-3, for both nonadulterated and adulterated milk samples, which allowed for effective detection and quantification of whey adulteration. Calibration curves for CMP-1 and CMP-3 were generated on high-resolution (LC–HRMS) and low-resolution (LC–LRMS) mass spectrometers, yielding R 2 values between 0.91 and 0.99. The calibration curves displayed adequate linearity, and variability in ionization efficiency underscored the need for an internal standard to ensure greater reproducibility. CMP-3 is proposed as a promising biomarker and/or in-house standard for quantifying whey adulteration in milk, offering a reliable and reproducible approach for routine LC–MS analysis.

4 August 2025 in Antibiotics
Verified
Journal Article
Open access
PDF file
DADaniel Alejandro Castellar Almonacid
Daniel Alejandro Castellar Almonacid
KCKelin Johana Cuero-Amu
Kelin Johana Cuero-Amu
JMJose David Mendoza-Mendoza
Jose David Mendoza-Mendoza
NANatalia Ardila-Chantré
Natalia Ardila-Chantré
FCFernando Jose Chavez
Fernando Jose Chavez
RFRicardo Fierro-Medina
Ricardo Fierro-Medina
Palindromic antimicrobial peptides (PAMs) constitute versatile scaffolds for the design and optimization of anticancer agents with applications in therapy, diagnosis, and/or monitoring. In the present study, fluorolabeled peptides derived from the palindromic sequence RWQWRWQWR containing fluorescent probes, such as 2-Aminobenzoyl, 5(6)-Carboxyfluorescein, and Rhodamine B, were obtained. RP-HPLC analysis revealed that the palindromic peptide conjugated to Rhodamine B (RhB-RWQWRWQWR) exhibited the presence of isomers, likely corresponding to the open-ring and spiro-lactam forms of the fluorescent probe. This equilibrium is dependent on the peptide sequence, as the RP-HPLC analysis of dimeric peptide (RhB-RRWQWR-hF-KKLG)2K-Ahx did not reveal the presence of isomers. The antibacterial activity of the fluorescent peptides depends on the probe attached to the sequence and the bacterial strain tested. Notably, some fluorescent peptides showed activity against reference strains as well as sensitive, resistant, and multidrug-resistant clinical isolates of E. coli, S. aureus, and E. faecalis. Fluorolabeled peptides 1-Abz (MIC = 62 µM), RhB-1 (MIC = 62 µM), and Abz-1 (MIC = 31 µM) exhibited significant activity against clinical isolates of E. coli, S. aureus, and E. faecalis, respectively. The RhB-1 (IC50 = 61 µM), Abz-1 (IC50 = 87 µM), and RhB-2 (IC50 = 35 µM) peptides exhibited a rapid, significant, and concentration-dependent cytotoxic effect on HeLa cells, accompanied by morphological changes characteristic of apoptosis. RhB-1 (IC50 = 18 µM) peptide also exhibited significant cytotoxic activity against breast cancer cells MCF-7. These conjugates remain valuable for elucidating the possible mechanisms of action of these novel anticancer peptides. Rhodamine-labeled peptides displayed cytotoxicity comparable to that of their unlabeled analogues, suggesting that cellular internalization constitutes a critical early step in their mechanism of action. These findings suggest that cell death induced by both unlabeled and fluorolabeled peptides proceeds predominantly via apoptosis and is likely contingent upon peptide internalization. Functionalization at the N-terminal end of the palindromic sequence can be evaluated to develop systems for transporting non-protein molecules into cancer cells.